Oral carcinogenesis is a multifactorial process involving numerous genetic events that alter normal functions of oncogenes and tumour suppressor genes.
This may increase the production of growth factors or the number of receptors on the cell surface, and/or increase transcription factors or intracellular signal messengers.
Together with the loss of tumour suppressor activity, these changes lead to a cell phenotype that can increase cell proliferation, with loss of cell cohesion, and infiltration of adjacent tissue thus causing distant metastasis. Molecular pathology is responsible for defining the molecular mechanisms that underlie the onset of oral precancer and cancer.
The aim of this review is to describe recent advances in our understanding of the molecular control of the innumerable pathways related to these processes. These may lead to short- or medium term improvements in the diagnosis and prognosis of oral precancerous and cancerous lesions and to the development of novel therapeutic approaches to this disease.
Authors: J. CAMPO-TRAPERO, J. CANO-SÁNCHEZ, B. PALACIOS-SÁNCHEZ, JJ. SÁNCHEZ-GUTIERREZ, M.A. GONZÁLEZ-MOLES and A. BASCONES-MARTÍNEZ
Source: https://ar.iiarjournals.org/
Products 27 March 2026
Garrison Dental Solutions has announced important enhancements to its Quad Matrix System with the release of updated Quad Wedges, building on the system’s strong clinical adoption for complex Class...
Products 20 February 2026
DEXIS™, a global leader in dental imaging, today introduced its most advanced update yet to the DTX Studio™ platform—bringing AI-driven diagnostics and multi-site connectivity designed to...
Periodontology 10 September 2025
To update the findings of a systematic review from the year 2016 on the evidence for the accuracy and potential benefits of cone beam computed tomography (CBCT) in periodontal diagnostics.
New surgical kits, a 6.0-mm implant, and upgraded accessories elevate the clinical ease and versatility of the company’s flagship system.
News 31 January 2025
Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025.
Products 08 June 2026
Study Club is now included with Practice Membership, while Spear All Access adds coaching, analytics, and implementation support for growing practices
News 08 June 2026
Skytale G roup (“Skytale”), an investment banking, management consulting, and private capital firm specializing in healthcare and consumer businesses, is pleased to announce that i
News 08 June 2026
Dental Service Organization Continues Florida Expansion with New Practice in Prime Mixed-Use Community
Editorials 08 June 2026
A decade past labs and late-night study sessions, members of the Class of 2016 offered some advice for Texas A&M College’s newest graduates.
Periodontology 08 June 2026
This peer-reviewed periodontology article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment...